References

  1. Deuschl G, Beghi E, Fazekas F, et al. The burden of neurological diseases in Europe: an analysis for the Global Burden of Disease Study 2017. Lancet Public Health. 2020;5(10):e551-e67.
  2. Pfizer Australia. Headache and Migraine. 2005.
  3. Deloitte Access Economics Report. Migraine in Australia whitepaper: Measuring the impact. 2018.
  4. Ashina S, Mitsikostas DD, Lee MJ, et al. Tension-type headache. Nat Rev Dis Primers 2021;7(1):24.
  5. Leonardi M, Steiner TJ, Scher AT, et al. The global burden of migraine: measuring disability in headache disorders with WHO’s Classification of Functioning, Disability and Health (ICF). J Headache Pai 2005;6(6):429–40.
  6. Ebahimzadeh K, Gholipour M, Samadian M, et al. A comprehensive review on the role of genetic factors in the pathogenesis of migraine. J Mol Neurosci 2021;71(10):1987–2006.
  7. Silberstein S. Migraine. MSD Manual 2022. At: msdmanuals.com/en-au/professional/neurologic-disorders/headache/migraine#v7528174
  8. Charles A. Vasodilation out of the picture as a cause of migraine headache. Lancet Neurol 2013;12(5):419–20.
  9. Amiri P, Kazeminasab S, Nejadghaderi SA, et al. Migraine: A review on its history, global epidemiology, risk factors, and comorbidities. Front Neurol 2021;12:800605.
  10. Wober C, Wober-Bingol C. Triggers of migraine and tension-type headache. Handb Clin Neurol 2010;97:161–72.
  11. Steel SJ, Robertson CE, Whealy MA. Current understanding of the pathophysiology and approach to tension-type headache. Curr Neurol Neurosci Rep 2021;21(10):56.
  12. Classification Committee of The International Headache Society. International Classification of Headache

THIS IS A CPD ARTICLE. YOU NEED TO BE A PSA MEMBER AND LOGGED IN TO READ MORE.